Personalised pharmacometabolomic optimisation of treatment for hypertension

Project Information

Hypermarker

Grant agreement ID: 101095480

DOI

10.3030/101095480

EC signature date 8 December 2022

Start date 1 January 2023

End date 31 December 2026

Funded under

• Health

Total cost

€ 8 046 250,00

EU contribution

€ 8 046 250,00

Coordinated by

UNIVERSITAIR MEDISCH CENTRUM UTRECHT
Netherlands

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Data Management Plan (2)

Data management plan
Updated Data management plan

Update to D1.1 Data management plan

Documents, reports (7)

Validation report of extended metabolomics/exposomics platform
Report on the economic burden of chronic, uncontrolled hypertension in Europe
Completed study initiation package with PPIE input
Report on the best identified prediction method based on the accuracy
Development of the causal map between selected markers
Plan for dissemination and communication activities
Report on return of results policies for large-scale pharmacometabolomics research

Report on return of results policies for large-scale pharmacometabolomics research

Websites, patent fillings, videos etc. (1)

Project website

Publications

Peer reviewed articles (3)

Towards responsible surveillance in preventive health data-AI research

Author(s): Sam H. A. Muller, Johannes J. M. van Delden, Ghislaine J. M. W. van Thiel, null null
Published in: PLOS Digital Health, Issue 4, 2025, ISSN 2767-3170
Publisher: Public Library of Science (PLoS)
DOI: 10.1371/JOURNAL.PDIG.0001146

Transforming clinical decisions with artificial intelligence: the HYPERMARKER project

Author(s): Dipak Kotecha, Thomas Hankemeier, Diederick E Grobbee
Published in: European Heart Journal, 2026, ISSN 0195-668X
Publisher: Oxford University Press (OUP)
DOI: 10.1093/EURHEARTJ/EHAG165

Diffused responsibilities in technology-driven health research: The case of artificial intelligence systems in decentralized clinical trials

Author(s): Sam H.A. Muller, Tessa I. van Rijssel, Ghislaine J.M.W. van Thiel
Published in: Drug Discovery Today, Issue 30, 2025, ISSN 1359-6446
Publisher: Elsevier BV
DOI: 10.1016/j.drudis.2025.104309

Other (1)

Modulation of antihypertensive drug effectiveness by dietary consumption: a scoping review

Author(s): Miah, Bristi; Knikman, Jonathan; van der Schouw, Yvonne; Geleijnse, Marianne
Published in: 2024
Publisher: Not applicable
DOI: 10.5281/ZENODO.10664848